News Release from :
For more information, contact:
YOFiMeter™ to Connect Glucose Meter with AT&T
Connected Glucose Meter Wirelessly Transmits Patient Data to Caregivers
Las VEGAS, Jan. 5, 2016 – AT&T and YOFiMeter™ have reached an agreement that will enable people with diabetes to wirelessly transmit their blood sugar levels, other biometric data and voice notes. Once cleared by the FDA, the YOFiMeter Connected Glucose Meter will open another line of communication between caregivers and patients over AT&T’s highly secure network.
YOFiMeter works with a diverse team of endocrinologists, practitioners, healthcare institutions, patients and other stakeholders to create a device with a “clean slate” approach, a device that fits into their lives without disrupting it.
“YOFiMeter believes in a “clean slate” approach to connected health devices, making it easier for patients to fit into their lives without disruption,” said Gad Shaanan, inventor and founder of YOFiMeter. “The fundamental thought was not to invent technologies for testing, but to invent a new experience of testing, recording and tracking data. Today’s blood glucose meters require multiple steps to take a basic blood glucose reading. Repeating the process multiple times per day makes it cumbersome, enticing consumers to skip tests. YOFiMeter accomplishes this and more within seconds, from pulling it out of your pocket to putting it back. YOFiMeter is ready anytime, anywhere, with the ability to test on the go, without skipping a beat. We know consumers, and the value of removing barriers and time required of a process that needs to be repeated multiple times a day.”
“For those managing diabetes, it’s important to stay proactive. Using our network, AT&T is helping caregivers and providers deliver a seamless experience that gives patients the information they need to take control of their health,” Chris Penrose, Senior Vice President of AT&T’s Internet of Things Organization. “YOFiMeter’s connected glucose meter is a great example of how technology, particularly when it can be taken with you and stay connected, is solving real healthcare problems.”
YofiMeter is working with the FDA on the clearance process with production expected to start in early 2016. For more information about YOFiMeter go to www.yofimeter.com
AT&T products and services are provided or offered by subsidiaries and affiliates of AT&T Inc. under the AT&T brand and not by AT&T Inc.
AT&T Inc. (NYSE:T) helps millions around the globe connect with leading entertainment, mobile, high speed Internet and voice services. We’re the world’s largest provider of pay TV. We have TV customers in the U.S. and 11 Latin American countries. In the U.S., our wireless network offers the nation’s strongest LTE signal and the most reliable 4G LTE network. We offer the best global wireless coverage*. And we help businesses worldwide serve their customers better with our mobility and secure cloud solutions.
Additional information about AT&T products and services is available at http://about.att.com. Follow our news on Twitter at @ATT, on Facebook at http://www.facebook.com/att and YouTube at http://www.youtube.com/att.
© 2015 AT&T Intellectual Property. All rights reserved. AT&T, the Globe logo and other marks are trademarks and service marks of AT&T Intellectual Property and/or AT&T affiliated companies. All other marks contained herein are the property of their respective owners.
Signal strength and reliability claims based on nationwide carriers’ 4G LTE. Signal strength claim based ONLY on avg. 4G LTE signal strength. 4G LTE not available everywhere.
*Global coverage claim based on offering discounted voice and data roaming; LTE roaming; voice roaming; and world-capable smartphone and tablets in more countries than any other U.S. based carrier. International service required. Coverage not available in all areas. Coverage may vary per country and be limited/restricted in some countries.
Cautionary Language Concerning Forward-Looking Statements:
Information set forth in this news release contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results may differ materially. A discussion of factors that may affect future results is contained in AT&T's filings with the Securities and Exchange Commission. AT&T disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise.
FDA Clearance and launch schedule:
YofiMeter is working with the FDA and is in the clearance process right now. We hope to get clearance and be in production by early 2016.